Quarterly results
Latest results
2020 First quarter
We announced our first quarter 2020 results on Wednesday 29 April.
Highlights
Downloads
- Q1 2020 results announcement PDF - 597.7KB
- Q1 2020 results slides PDF - 601.8KB
- Q1 2020 results transcript PDF - 146.3KB
- Q1 2020 results infographic PDF - 445.4KB
- Q1 2020 US dollar translation PDF - 89.5KB
- Q1 2020 pre announcement aide memoire PDF - 681.9KB
- 30 March 2020: Consumer Healthcare product sales category changes XLSX - 16.7KB
-
2010 Fourth Quarter - released 03 February 2011
Andrew Witty, CEO, discusses our fourth quarter results 2010.
Key highlights
- Long-term share buy-back programme initiated
- 2010 dividend up 7% to 65p
-
2010 Third Quarter - released 21 October 2010
Andrew Witty, CEO, discusses our third quarter results 2010
Key highlights
- Q3 EPS before major restructuring of 28.2p
- Q3 dividend up 7% to 16p
-
2010 Second Quarter - released 21 July 2010
Andrew Witty, CEO, discusses our second quarter results 2010.
Key highlights
- Q2 EPS before major restructuring 2.6p (29.3p excluding pre-announced legal charge)
- Q2 dividend increased 7% to 15p
-
2010 First Quarter - released 28 April 2010
Andrew Witty, CEO, discusses our first quarter results 2010.
Key highlights
- Q1 sales £7.4bn up 13% CER
- Underlying sales (excluding pandemic products) up 4% CER
Other key information
-
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
-
Press releases
Keep up to date with our news and recent announcements
-
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
-
Our pipeline
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients and payers
